Analytical Data
-
Gene name
LRRC39
- Application
-
Alternative Names
LRRC39; UNQ6500/PRO21368; Leucine-rich repeat-containing protein 39; Myosin-interacting M-band-associated stress-responsive protein; Myomasp
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96DD0
-
Expression Region
1-335aa
-
AA Sequence
MTENVVCTGAVNAVKEVWEKRIKKLNEDLKREKEFQHKLVRIWEERVSLTKLREKVTREDGRVILKIEKEEWKTLPSSLLKLNQLQEWQLHRTGLLKIPEFIGRFQNLIVLDLSRNTISEIPPGIGLLTRLQELILSYNKIKTVPKELSNCASLEKLELAVNRDICDLPQELSNLLKLTHLDLSMNDFTTIPLAVLNMPALEWLDMGSNKLEQLPDTIERMQNLHTLWLQRNEITCLPQTISNMKNLGTLVLSNNKLQDIPVCMEEMANLRFVNFRDNPLKLKVSLPPSEGTDEEEERELFGLQFMHTYIQESRRRADHQVNGSTTLPISINTDG
-
Molecular Weight
65.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRRC39, or leucine-rich repeat containing 39, is a protein that has garnered interest due to its potential role in various biological processes, including cell signaling, development, and disease mechanisms. It is characterized by a series of leucine-rich repeats, which are structural motifs often involved in protein-protein interactions, suggesting that LRRC39 may play a critical role in modulating cellular pathways. Recent studies have indicated that LRRC39 might be implicated in the regulation of gene expression and chromatin dynamics, particularly in the context of cancer and other pathological conditions. The production of recombinant LRRC39 protein provides a valuable tool for understanding its functional properties and interactions within cells. By utilizing recombinant DNA technology, researchers can generate large quantities of this protein, facilitating in vitro studies that aim to elucidate its biochemical functions and structural characteristics. Investigating the role of LRRC39 within specific signaling pathways may reveal its contributions to cellular processes and potential implications in disease contexts, thereby offering insights that could inform therapeutic strategies. The ongoing research into LRRC39 is pivotal for uncovering the molecular underpinnings of its function and may lead to advancements in the understanding of complex biological systems and the development of new interventions in cancer and other disorders.
